{"id":"tobradex","rwe":[],"tags":[],"trials":[],"_chembl":null,"aliases":[],"patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=Tobradex","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T02:20:31.012510+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T02:20:37.356136+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=Tobradex","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T02:20:38.014729+00:00"},"mechanism.target_chembl":{"url":"","method":"api_direct","source":"ChEMBL mechanism: 70S ribosome inhibitor","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T02:20:39.062169+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1747/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T02:20:38.727610+00:00"}},"offLabel":[],"timeline":[],"_dailymed":{"setId":"7f310e0e-0d3b-493d-b6c4-238493a2a9b9","title":"TOBRADEX (TOBRAMYCIN AND DEXAMETHASONE) OINTMENT [NOVARTIS PHARMACEUTICALS CORPORATION]"},"ecosystem":[],"_scrapedAt":"2026-03-28T01:39:12.602Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T02:20:40.328582+00:00","fieldsConflicting":0,"overallConfidence":0.95},"biosimilars":[],"competitors":[],"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT07332936","phase":"NA","title":"Tobradex as Intracanal Medicament","status":"COMPLETED","sponsor":"Umm Al-Qura University","startDate":"2023-07-01","conditions":"Symptomatic Irreversible Pulpitis, Postoperative Endodontic Pain Following Emergency Root Canal Treatment","enrollment":43},{"nctId":"NCT02137161","phase":"PHASE4","title":"Bromfenac to Reduce Inflammation in Patients With Pseudoexfoliation Syndrome After Cataract Surgery","status":"COMPLETED","sponsor":"Azienda USL Reggio Emilia - IRCCS","startDate":"2013-11","conditions":"Cataract, Pseudoexfoliation Syndrome","enrollment":62},{"nctId":"NCT06404541","phase":"PHASE4","title":"A Comparative Study Between Preservative With Benzalkonium Chloride vs Preservative Free Eye Drops on the Ocular Surface","status":"ACTIVE_NOT_RECRUITING","sponsor":"Kasr El Aini Hospital","startDate":"2024-01-10","conditions":"Ocular Surface Disease, Dry Eye Syndromes","enrollment":60},{"nctId":"NCT02528123","phase":"NA","title":"VisuMax Femtosecond Laser Small Incision Lenticule Extraction for the Correction of High Myopia","status":"COMPLETED","sponsor":"London Vision Clinic","startDate":"2016-04","conditions":"Myopia, Refractive Errors","enrollment":114},{"nctId":"NCT06200727","phase":"NA","title":"Platelet-rich Fibrin(PRF) Membrane in Ophthalmic Diseases","status":"UNKNOWN","sponsor":"Lei Du","startDate":"2023-01-01","conditions":"Platelet-rich Fibrin, Macular Holes, Pterygium","enrollment":170},{"nctId":"NCT05362253","phase":"NA","title":"Micro-Conjunctival Autografting Combined With Amniotic Membrane Transplantation Treating Recurrent Pterygium Trial","status":"COMPLETED","sponsor":"Yifeng Yu","startDate":"2021-03-01","conditions":"Recurrent Pterygium, Micro-Conjunctival Autografting Combined With Amniotic Membrane Transplantation","enrollment":40},{"nctId":"NCT05314673","phase":"PHASE4","title":"Preoperative Bevacizumab Injection in Primary Pterygium in Tunisian Patients","status":"COMPLETED","sponsor":"University Hospital Fattouma Bourguiba","startDate":"2019-01-01","conditions":"Pterygium","enrollment":60},{"nctId":"NCT01560962","phase":"NA","title":"Efficacy of Over the Counter (OTC) Povidone-Ioldine 5% for Treatment of Acute or Chronic Blepharitis","status":"TERMINATED","sponsor":"Southern California Institute for Research and Education","startDate":"2012-01","conditions":"Blepharitis","enrollment":100},{"nctId":"NCT03739528","phase":"PHASE3","title":"Levo-Dexa vs. Tobra+Dexa for Prevention and Treatment of Inflammation and Prevention of Infection in Cataract Surgery","status":"COMPLETED","sponsor":"NTC srl","startDate":"2018-09-03","conditions":"Cataract","enrollment":808},{"nctId":"NCT04457063","phase":"PHASE2, PHASE3","title":"Endothelial Cell Loss After Penetrating Keratoplasty","status":"COMPLETED","sponsor":"Alexandria University","startDate":"2018-07-01","conditions":"Keratoconus","enrollment":8},{"nctId":"NCT04322500","phase":"NA","title":"Probiotics for Chalaziosis Treatment in Children","status":"COMPLETED","sponsor":"University of Molise","startDate":"2019-02-01","conditions":"Chalazion","enrollment":26},{"nctId":"NCT04342507","phase":"NA","title":"Probiotics for Treatment of Chalazion in Adults","status":"COMPLETED","sponsor":"University of Molise","startDate":"2019-02-01","conditions":"Chalazion","enrollment":20},{"nctId":"NCT04022811","phase":"PHASE4","title":"Effect of Bromfenac on Pain Related to Pterygium Surgery","status":"COMPLETED","sponsor":"Zhongshan Ophthalmic Center, Sun Yat-sen University","startDate":"2016-10","conditions":"Pterygium, Pain","enrollment":60},{"nctId":"NCT03975374","phase":"EARLY_PHASE1","title":"To Study Efficacy and Safety of Tobradex Eye Drop Suspension vs Tobramycin/Dexamethasone Ophthalmic Suspension","status":"UNKNOWN","sponsor":"Sutphin Drugs","startDate":"2019-06-15","conditions":"Blepharo Conjunctivitis","enrollment":5000},{"nctId":"NCT01230593","phase":"NA","title":"Chalazion Conservative Treatment Trial","status":"COMPLETED","sponsor":"McMaster University","startDate":"2010-11","conditions":"Chalazion Unspecified Eye, Unspecified Eyelid, Chalazion Left Eye, Unspecified Eyelid, Chalazion Right Eye, Unspecified Eyelid","enrollment":150},{"nctId":"NCT03105466","phase":"NA","title":"Prospective Study of Deep Anterior Lamellar Keratoplasty Using Acellular Porcine Cornea","status":"UNKNOWN","sponsor":"Zhongshan Ophthalmic Center, Sun Yat-sen University","startDate":"2016-02","conditions":"Corneal Transplantation","enrollment":50},{"nctId":"NCT02817191","phase":"NA","title":"Effects of Holy-Comod and Tears Naturale Forte in Patients After Phaco+IOL","status":"UNKNOWN","sponsor":"Sun Yat-sen University","startDate":"2016-06","conditions":"Age-related Cataract","enrollment":80},{"nctId":"NCT02540785","phase":"NA","title":"Early Changes Between Lenticule Extraction and Small-Incision Lenticule Extraction","status":"COMPLETED","sponsor":"Sun Yat-sen University","startDate":"2014-04","conditions":"Myopia, Astigmatism","enrollment":41},{"nctId":"NCT02551796","phase":"NA","title":"Early Changes Among FLEx, LASIK and FS-LASIK","status":"COMPLETED","sponsor":"Sun Yat-sen University","startDate":"2015-09","conditions":"Myopia, Astigmatism","enrollment":75},{"nctId":"NCT02734459","phase":"PHASE3","title":"A Bioequivalence Study to Compare the Pharmacokinetics (PK) Of Marketed Product TobraDex® To An Experimental Ophthalmic Sterile Ointment Containing Tobramycin And Dexamethasone In Aqueous Humor In Patients Undergoing Indicated Cataract Surgery","status":"COMPLETED","sponsor":"Semler Research Center Pvt. Ltd.","startDate":"2013-11","conditions":"Bilateral Cataract","enrollment":756},{"nctId":"NCT00083551","phase":"PHASE3","title":"UARK 98-026 TT II: Multiple Myeloma Evaluating Anti-Angiogenesis With Thalidomide and Post-Transplant Consolidation Chemotherapy","status":"COMPLETED","sponsor":"University of Arkansas","startDate":"1998-08","conditions":"Multiple Myeloma","enrollment":668},{"nctId":"NCT02558218","phase":"NA","title":"Postoperative Discomfort and Ocular Redness Following Phacoemulsification Surgery","status":"COMPLETED","sponsor":"Democritus University of Thrace","startDate":"2015-01","conditions":"Cataract","enrollment":80},{"nctId":"NCT01103401","phase":"NA","title":"Ketorolac Plus Tobramycin/Dexamethasone Versus Tobramycin/Dexamethasone After Uneventful Phacoemulsification Surgery","status":"COMPLETED","sponsor":"Veroia General Hospital","startDate":"2009-10","conditions":"Cataract","enrollment":145},{"nctId":"NCT01102244","phase":"PHASE3","title":"A Study to Evaluate the Clinical Efficacy and Safety of Tobradex® ST Compared to Azasite® in the Treatment of Subjects With Moderate to Severe Chronic Blepharitis","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2010-04","conditions":"Blepharitis","enrollment":122},{"nctId":"NCT00404937","phase":"PHASE3","title":"Tobradex BID Compared to TOBRADEX and TOBREX/Vehicle","status":"WITHDRAWN","sponsor":"Alcon Research","startDate":"2006-12","conditions":"Post-surgical Inflammation","enrollment":""},{"nctId":"NCT00362895","phase":"PHASE3","title":"A Bioequivalence Study of Tobradex AF","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2006-04","conditions":"Cataract","enrollment":995},{"nctId":"NCT01028027","phase":"PHASE3","title":"Loteprednol and Tobramycin Versus Tobramycin and Dexamethasone, in the Treatment of Blepharokeratoconjunctivitis","status":"COMPLETED","sponsor":"Bausch & Lomb Incorporated","startDate":"2009-10","conditions":"Conjunctivitis, Keratitis, Blepharitis","enrollment":357},{"nctId":"NCT00447577","phase":"PHASE4","title":"Zylet vs TobraDex in Blepharokeratoconjunctivitis","status":"COMPLETED","sponsor":"Bausch & Lomb Incorporated","startDate":"2007-01","conditions":"Blepharokeratoconjunctivitis","enrollment":276},{"nctId":"NCT00532961","phase":"PHASE4","title":"Ocular Tolerance and Intraocular Pressure (IOP) Effects of Zylet Versus Tobradex","status":"COMPLETED","sponsor":"Bausch & Lomb Incorporated","startDate":"2005-02","conditions":"Inflammation","enrollment":310},{"nctId":"NCT01227915","phase":"PHASE3","title":"Effectiveness Comparison Between the Drugs TOBRACORT® and TOBRADEX® in Reducing the Signs and Symptoms of Acute Bacterial Conjunctivitis","status":"UNKNOWN","sponsor":"Azidus Brasil","startDate":"2011-02","conditions":"Acute Bacterial Conjunctivitis","enrollment":70},{"nctId":"NCT00576251","phase":"PHASE3","title":"TOBRADEX Ophthalmic Suspension Versus Tobramycin 0.3%/Dexamethasone 0.05% Ophthalmic Suspension","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2007-10","conditions":"Ocular Inflammation Associated With Blepharaconjunctivitis","enrollment":221},{"nctId":"NCT00695435","phase":"PHASE1","title":"Tobramycin Tear Concentrations","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2008-06","conditions":"Dry Eye","enrollment":21},{"nctId":"NCT00992355","phase":"NA","title":"Tobramycin-Dexamethasone Versus Tobramycin-Dexamethasone Plus Ketorolac After Phacoemulsification Surgery","status":"COMPLETED","sponsor":"Veroia General Hospital","startDate":"2009-01","conditions":"Cataract","enrollment":97},{"nctId":"NCT00781300","phase":"PHASE4","title":"Intraocular Pressure With Loteprednol and Dexamethasone","status":"COMPLETED","sponsor":"Federal University of São Paulo","startDate":"2006-03","conditions":"Glaucoma, Open-Angle, Ocular Hypertension","enrollment":35},{"nctId":"NCT00473070","phase":"PHASE3","title":"A Clinical Study of Tobradex AF","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2006-11","conditions":"Cataract","enrollment":900}],"_emaApprovals":[],"_faersSignals":[{"count":197,"reaction":"EYE PAIN"},{"count":165,"reaction":"OFF LABEL USE"},{"count":134,"reaction":"HEADACHE"},{"count":134,"reaction":"NAUSEA"},{"count":133,"reaction":"VISION BLURRED"},{"count":129,"reaction":"FATIGUE"},{"count":124,"reaction":"DRUG INEFFECTIVE"},{"count":124,"reaction":"OCULAR HYPERAEMIA"},{"count":119,"reaction":"EYE IRRITATION"},{"count":114,"reaction":"PAIN"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"chemblId":"CHEMBL1747"},"formularyStatus":[],"_approvalHistory":[{"date":"20200424","type":"SUPPL","sponsor":"NOVARTIS","applicationNumber":"NDA050616"},{"date":"20210514","type":"SUPPL","sponsor":"NOVARTIS","applicationNumber":"NDA050616"},{"date":"20030318","type":"SUPPL","sponsor":"NOVARTIS","applicationNumber":"NDA050616"},{"date":"20030318","type":"SUPPL","sponsor":"NOVARTIS","applicationNumber":"NDA050616"},{"date":"19960926","type":"SUPPL","sponsor":"NOVARTIS","applicationNumber":"NDA050616"},{"date":"19990928","type":"SUPPL","sponsor":"NOVARTIS","applicationNumber":"NDA050616"},{"date":"20040715","type":"SUPPL","sponsor":"NOVARTIS","applicationNumber":"NDA050616"},{"date":"19941027","type":"SUPPL","sponsor":"NOVARTIS","applicationNumber":"NDA050616"},{"date":"19990205","type":"SUPPL","sponsor":"NOVARTIS","applicationNumber":"NDA050616"},{"date":"19920521","type":"SUPPL","sponsor":"NOVARTIS","applicationNumber":"NDA050616"},{"date":"19880928","type":"ORIG","sponsor":"NOVARTIS","applicationNumber":"NDA050616"},{"date":"19990428","type":"SUPPL","sponsor":"NOVARTIS","applicationNumber":"NDA050616"},{"date":"19930831","type":"SUPPL","sponsor":"NOVARTIS","applicationNumber":"NDA050616"},{"date":"19890627","type":"SUPPL","sponsor":"NOVARTIS","applicationNumber":"NDA050616"},{"date":"20210514","type":"SUPPL","sponsor":"NOVARTIS","applicationNumber":"NDA050616"},{"date":"20021211","type":"SUPPL","sponsor":"NOVARTIS","applicationNumber":"NDA050616"},{"date":"20030318","type":"SUPPL","sponsor":"NOVARTIS","applicationNumber":"NDA050616"},{"date":"20040715","type":"SUPPL","sponsor":"NOVARTIS","applicationNumber":"NDA050616"},{"date":"19960318","type":"SUPPL","sponsor":"NOVARTIS","applicationNumber":"NDA050616"},{"date":"19990407","type":"SUPPL","sponsor":"NOVARTIS","applicationNumber":"NDA050616"},{"date":"19920203","type":"SUPPL","sponsor":"NOVARTIS","applicationNumber":"NDA050616"},{"date":"19980529","type":"SUPPL","sponsor":"NOVARTIS","applicationNumber":"NDA050616"},{"date":"19961129","type":"SUPPL","sponsor":"NOVARTIS","applicationNumber":"NDA050616"},{"date":"19920917","type":"SUPPL","sponsor":"NOVARTIS","applicationNumber":"NDA050616"},{"date":"20220816","type":"SUPPL","sponsor":"HARROW EYE","applicationNumber":"NDA050818"},{"date":"20220816","type":"SUPPL","sponsor":"HARROW EYE","applicationNumber":"NDA050818"},{"date":"20100803","type":"SUPPL","sponsor":"HARROW EYE","applicationNumber":"NDA050818"},{"date":"20090213","type":"ORIG","sponsor":"HARROW EYE","applicationNumber":"NDA050818"},{"date":"20260317","type":"SUPPL","sponsor":"HARROW EYE","applicationNumber":"NDA050818"},{"date":"20220816","type":"SUPPL","sponsor":"HARROW EYE","applicationNumber":"NDA050818"}],"developmentCodes":[],"ownershipHistory":[],"publicationCount":55,"therapeuticAreas":["Other"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"marketed","status":"active","brandName":"Tobradex","genericName":"Tobradex","companyName":"Azidus Brasil","companyId":"azidus-brasil","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T02:20:40.328582+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":true,"score":1}}